The utility of magnetic resonance imaging in cardiac tissue regeneration trials

Nature Clinical Practice Cardiovascular Medicine

Volumn 3, Issue SUPPL. 1, 2006, Pages

  Fuster, Valentin ^a   Sanz, Javier ^a   Viles Gonzalez, Juan F ^a   Rajagopalan, Sanjay ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cell therapy; CMRI; Echocardiography; Heart failure; Myocardial infarction

Indexed keywords

CONTRAST MEDIUM; DEOXYHEMOGLOBIN; DOBUTAMINE; FLUORODEOXYGLUCOSE; GADOLINIUM; INOTROPIC AGENT; OXYGEN; OXYHEMOGLOBIN; PHOSPHORUS 31;

ACUTE HEART INFARCTION; ADOPTIVE IMMUNOTHERAPY; ANGIOGENESIS; ARTICLE; BONE MARROW CELL; CARDIOMYOPLASTY; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL LINEAGE; CLINICAL TRIAL; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; HEART FUNCTION; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEMATOPOIETIC CELL; HUMAN; IMAGING SYSTEM; MEDICAL TECHNOLOGY; MICROCIRCULATION; MITOSIS; MORPHOLOGY; NERVOUS SYSTEM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN BLOOD LEVEL; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PLASTICITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLE SIZE; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL; STRESS ECHOCARDIOGRAPHY; TISSUE REGENERATION;

ADENOSINE TRIPHOSPHATE; CELL TRANSPLANTATION; CLINICAL TRIALS; DOBUTAMINE; GADOLINIUM; HEART; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDIAL INFARCTION; MYOCARDIUM; OXYGEN; PHOSPHOCREATINE; REGENERATION; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; STEM CELL TRANSPLANTATION;

EID: 33644632216     PISSN: 17434297     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpcardio0418     Document Type: Article

References (27)

1. Balsam LB et al. (2004) Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428: 668-673
2. Murry CE et al. (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428: 664-668
3. Rector TS and Cohn JN (1994) Prognosis in congestive heart failure. Annu Rev Med 45: 341-350
4. Lima JA et al. (1995) Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 92: 1117-1125
5. Wagner A et al. (2003) Contrast-enhanced MRI and routine single photon emission computed tomography (SPEC)) perfusion imaging for detection of subendocardial myocardial infarcts: An imaging study. Lancet 361: 374-379
6. Klein C et al. (2002) Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: Comparison with positron emission tomography. Circulation 105: 162-167
7. Kim RJ et al. (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343: 1445-1453
8. Selvanayagam JB et al. (2004) Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 110: 1535-1541
9. Bello D et al. (2003) Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing β-blocker therapy. Circulation 108: 1945-1953
10. Britten MB et al. (2003) Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): Mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108: 2212-2218
11. Cwajg JM et al. (2000) End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: Relation to rest-redistribution T1-201 tomography and dobutamine stress echocardiography. J Am Coll Cardiol 35: 1152-1161
12. Kim RJ and Shah DJ (2004) Fundamental concepts in myocardial viability assessment revisited: When knowing how much is "alive" is not enough. Heart 90: 137-140
13. Baumgartner H et al. (1998) Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: Correlation with histopathology in explanted hearts. J Am Coll Cardiol 32: 1701-1708
14. Hombach V et al. (2005) Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 26: 549-557
15. Kim RJ and Manning WJ (2004) Viability assessment by delayed enhancement cardiovascular magnetic resonance: Will low-dose dobutamine dull the shine? Circulation 109: 2476-1479
16. Vallee JP et al. (1999) Quantification of myocardial perfusion with FAST sequence and Gd bolus in patients with normal cardiac function. J Magn Reson Imaging 9: 197-203
17. Simons M et al. (2000) Clinical trials in coronary angiogenesis: Issues, problems, consensus: An expert panel summary. Circulation 102: E73-E86
18. Neubauer S et al. (1997) Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96: 2190-2196
19. Wacker CM et al. (2003) Susceptibility-sensitive magnetic resonance imaging detects human myocardium supplied by a stenotic coronary artery without a contrast agent. J Am Coll Cardiol 41: 834-840
20. Assmus B et al. (2002) Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106: 3009-3017
21. Strauer BE et al. (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106: 1913-1918
22. Perin EC et al. (2003) Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107: 2294-2302
23. Kang HJ et al. (2004) Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomised clinical trial. Lancet 363: 751-756
24. Wollert KC et al. (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 364: 141-148
25. Fernández-Avilés F et al. (2004) Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 95: 742-748
26. Smits PC et al. (2003) Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: Clinical experience with six-month follow-up. J Am Coll Cardiol 42: 2063-2069
27. Menasché P et al. (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: 1078-1083